Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Musculoskeletal  |  Neurology  |  Rheumatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Fibromyalgia Clinical Trials

A listing of Fibromyalgia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (132) clinical trials

Summit Research Network is enrolling in an investigational drug research study for fibromyalgia. Symptoms of fibromyalgia often include aches, pain, fatigue, pain when pressure is applied to certain places on the body called “tender points”, trouble sleeping, morning stiffness, headaches, problems with “foggy” thinking and memory. You may feel like …

Phase

Real World Examination of Fibromyalgia: Longitudinal Evaluation of Costs and Treatments (the REFLECTIONS STUDY) Please contact us for eligibility criteria.

Phase N/A

Children with fibromyalgia may experience significant pain, suffering and disability. We are currently enrolling in a clinical study for the treatment of fibromyalgia. You will be seen by a study physician who understands fibromyalgia for the duration of this study. Patient Inclusion Criteria: Be 12 - 16 years of age …

Phase

This study is for people who have Fibromyalgia (a condition that includes symptoms like widespread pain and tenderness, fatigue, and sleep problems). Researchers want to find out if a drug called sodium oxybate (already FDA approved for narcolepsy), taken as a combination of tablets and a liquid, is as safe …

Phase

Dr. John Rubino at Raleigh Medical Group is conducting a clinical research study on the treatment of the fibromyalgia syndrome. Participants between 18-70 years of age will receive at no cost to them: Study related physical exam Laboratory assessments Investigational study medication Compensation may also be provided.

Phase N/A

Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early

Humanity is experiencing since December 2019 a new pandemic by the novel SARS Coronavirus-19 (SARS-CoV-2). As of March 25 2020 418,099 documented case were reported worldwide; 18,608 patients died. The analysis of the clinical characteristics of these patients showed that the natural course of this disease, known with the acronym …

Phase

Evaluation and Diagnosis of People With Pain and Fatigue Syndromes

This screening protocol is designed to facilitate patient recruitment to the National Institute of Nursing Research (NINR) clinical research studies on pain and fatigue syndromes. This protocol will also validate the newly developed Saligan Fatigue Questionnaire. Patients must meet the specific requirements of an IRB-approved research study; this protocol serves …

Phase N/A

Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome

COVID-19 is a disease with an initial viral phase followed, usually at the 7th day, of an inflammatory state (cytokine storm) leading to respiratory distress, ICU admission and risk of death. Thus, several biological agents, antagonists of the different cytokines (IL-6, IL-1) have been used for patients with severe disease. …

Phase N/A

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19)

This study is a Phase 1 / 2 trial to determine the safety and efficacy of CYNK-001, an immunotherapy containing Natural Killer (NK) cells derived from human placental CD34+ cells and culture-expanded, in hospitalized patients with moderate COVID-19 disease.

Phase

Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia

The study is a randomized, double blinded, placebo-controlled, multicenter, multi-stage study with six parallel treatment arms consisting of either convalescent plasma, sarilumab, hydroxychloroquine, baricitinib, intravenous and subcutaneous placebo, or oral placebo. We plan to enroll 250 patients in each arm, with a total of 1500 patients yielding a statistical power …

Phase